Your browser doesn't support javascript.
loading
Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8.
Gounari, Maria; Ntoufa, Stavroula; Apollonio, Benedetta; Papakonstantinou, Nikos; Ponzoni, Maurilio; Chu, Charles C; Rossi, Davide; Gaidano, Gianluca; Chiorazzi, Nicholas; Stamatopoulos, Kostas; Ghia, Paolo.
Afiliação
  • Gounari M; Division of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele and Department of Onco-Hematology, Ospedale San Raffaele, Milan, Italy;
  • Ntoufa S; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece;
  • Apollonio B; Division of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele and Department of Onco-Hematology, Ospedale San Raffaele, Milan, Italy; Section of Internal Medicine, Università Vita-Salute San Raffaele, and.
  • Papakonstantinou N; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece;
  • Ponzoni M; Division of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele and Department of Onco-Hematology, Ospedale San Raffaele, Milan, Italy; Section of Internal Medicine, Università Vita-Salute San Raffaele, and Pathology Unit, IRCCS Istituto Scientifico San Raffaele, Milan, Italy;
  • Chu CC; The Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, NY;
  • Rossi D; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy; and.
  • Gaidano G; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy; and.
  • Chiorazzi N; The Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, NY;
  • Stamatopoulos K; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Ghia P; Division of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele and Department of Onco-Hematology, Ospedale San Raffaele, Milan, Italy; Section of Internal Medicine, Università Vita-Salute San Raffaele, and.
Blood ; 125(23): 3580-7, 2015 Jun 04.
Article em En | MEDLINE | ID: mdl-25900981
Subset #8 is a distinctive subset of patients with chronic lymphocytic leukemia (CLL) defined by the expression of stereotyped IGHV4-39/IGKV1(D)-39 B-cell receptors. Subset #8 patients experience aggressive disease and exhibit the highest risk for Richter transformation among all CLL. In order to obtain biological insight into this behavior, we profiled the antigen reactivity and signaling capacity of subset #8 vs other clinically aggressive stereotyped subsets, namely subsets #1 and #2. Twenty-seven monoclonal antibodies (mAbs) from subsets #1, #2, and #8 CLL clones were prepared as recombinant human immunoglobulin G1 and used as primary antibodies in enzyme-linked immunosorbent assays against representatives of the major classes of established antigenic targets for CLL. Subset #8 CLL mAbs exhibited broad polyreactivity as they bound to all antigens tested, in clear contrast with the mAbs from the other subsets. Antigen challenge of primary CLL cells indicated that the promiscuous antigen-binding activity of subset #8 mAbs could lead to significant cell activation, again in contrast to the less responsive CLL cells from subsets #1 and #2. These features constitute a distinctive profile for CLL subset #8, supporting the existence of distinct mechanisms of aggressiveness in different immunogenetic subsets of CLL.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Anticorpos Monoclonais / Anticorpos Antineoplásicos / Antígenos de Neoplasias Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Blood Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Anticorpos Monoclonais / Anticorpos Antineoplásicos / Antígenos de Neoplasias Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Blood Ano de publicação: 2015 Tipo de documento: Article